KING ABDULLAH MEDICAL CITY
๐ธ๐ฆSaudi Arabia
- Country
- ๐ธ๐ฆSaudi Arabia
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
- Conditions
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 204
- Registration Number
- NCT04099693
- Locations
- ๐ธ๐ฆ
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 338
- Registration Number
- NCT03957733
- Locations
- ๐ธ๐ฆ
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR
- First Posted Date
- 2019-05-07
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 30
- Registration Number
- NCT03940131
- Locations
- ๐ธ๐ฆ
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- King Abdullah Medical City
- Target Recruit Count
- 127
- Registration Number
- NCT02868827
- Locations
- ๐ธ๐ฆ
King Abdullah Medical City, Holy Capital, Mecca, Makkah Western, Saudi Arabia
ยฉ Copyright 2024. All Rights Reserved by MedPath